Home / Generics

Generics

News

Sun Pharma launches Ilumya in Japan and favipiravir in India posted 19/10/2020

Sun Pharmaceutical Industries Inc (Sun Pharma) announced that their innovative biopharmaceutical product, Ilumya (tildrakizum...

EMA recommends approval for arsenic trioxide and fampridine generics posted 25/09/2020

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) announced on 23 July 2020 that it...

Mylan launches first generic of Tecfidera in the US posted 15/09/2020

On 19 August 2020, Mylan announced the launch of the first US Food and Drug Administration (FDA) approved generic of Biogen's...

Lupin’s generic diabetes drug approved and asthma drug launched in US posted 06/09/2020

In August 2020, India-based generics maker Lupin announced that it has received approval from the US health regulator to mark...

Two additions to the South Korean generics market posted 28/08/2020

In South Korea, a generic drug for the treatment of breast cancer and generic versions of Pfizer’s popular smoking cessation...

 

Research

Medicare Part D favours generics over brand-name drugs posted 23/10/2020

A recent assessment of Medicare Part D [1] finds that insurance plans favour generic drugs over innovator products. Fewer tha...

Out-of-pocket spending caps cut patient spending by a third posted 02/10/2020

Out-of-pocket spending caps on specialty drugs in the US have reduced spending by 32% for some patients, finds a new study of...

Evaluating reasons for US low generics substitution rates posted 16/09/2020

The uptake of generic drug products in the US has not met expectations despite their widespread availability and relatively l...

Generics substitution in Finland: a pharmacy dispenser perspective posted 03/09/2020

In Finland, mandatory generic drug substitution was adopted in 2003 [1]. This is overseen by pharmaceutical staff who give ad...

Study reveals link between socioeconomic status and brand-name prescriptions posted 01/08/2020

A link between socioeconomic status and the prescription of brand-name drugs in the US, has been revealed by a team of resear...

 

General

Reforms to health policy needed in Europe posted 23/10/2020

The President of Medicines for Europe has made four key recommendations for European Union (EU) pharmaceutical policy,  ...

Structural reforms are required to make Japan’s healthcare system sustainable posted 09/10/2020

Japan’s healthcare system provides universal coverage and high-quality healthcare delivery. With relatively minor changes for...

The benefits of tracking generic drug quality posted 23/09/2020

Resources such as the US Food and Drug Administration’s (FDA) Sentinel Initiative should be used to their full potential in o...

Generics applications under review by EMA – July 2020 posted 22/07/2020

Generic medicines in Europe can be approved either centrally via the European Medicines Agency (EMA) or nationally via the lo...

HIV drug Kaletra appears on Russian black market posted 22/07/2020

There are several reports of a black market in Russia emerging for the HIV drug Kaletra, following claims that it can be used...